Placental mesenchymal dysplasia is associated with high rates of intrauterine growth restriction and fetal demise: A report of 11 new cases and a review of the literature

American Journal of Clinical Pathology

Volumn 126, Issue 1, 2006, Pages 67-78

  Pham, Truc ^a   Steele, Julie ^b   Stayboldt, Carla ^c   Chan, Linda ^b   Benirschke, Kurt ^a,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^c SCRIPPS MERCY HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Beckwith Wiedemann syndrome; Fetal demise; Intrauterine growth restriction; Placental mesenchymal dysplasia; Pseudo partial mole

Indexed keywords

ADULT; BECKWITH WIEDEMANN SYNDROME; CHORION VILLUS; CLINICAL ARTICLE; CONSULTATION; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; FEMALE; FETUS; FETUS DEATH; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; INCIDENCE; INTRAUTERINE GROWTH RETARDATION; META ANALYSIS; NEWBORN DEATH; PLACENTA DISORDER; PLACENTAL MESENCHYMAL DYSPLASIA; PRIORITY JOURNAL; REVIEW;

EID: 33745800866     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/RV45HRD53YQ2YFTP     Document Type: Review

References (44)

1. Moscoso G, Jauniaux E, Hustin J. Placental vascular anomaly with diffuse mesenchymal stem villous hyperplasia: a new clinico-pathological entity? Pathol Res Pract. 1991;187:324-328.
2. Chan YF, Sampson A. Placental mesenchymal dysplasia: a report of four cases with differentiation from partial hydatidiform mole. Aust N Z J Obstet Gynaecol 2003;43:475-479.
3. Takayama M, Soma H, Yaguchi S, et al. Abnormally large placenta associated with Beckwith-Wiedemann syndrome. Gynecol Obstet Invest. 1986;22:165-168.
4. Kitano Y, Ruchelli E, Weiner S, et al. Hepatic mesenchymal hamartoma associated with mesenchymal stem villous hyperplasia of the placenta. Fetal Diagn Ther. 2000;15:134-138.
5. Feinberg R, Lockwood C, Salafia C, et al. Sonographic diagnosis of a pregnancy with a diffuse hydatidiform mole and coexistent 46,XX fetus: a case report. Obstet Gynecol. 1988;72:485-488.
6. Jauniaux E, Nicolaides K, Hustin J. Perinatal features associated with placental mesenchymal dysplasia. Placenta. 1997;18:701-706.
7. McDermott M, Gillan J. Trophoblast basement membrane haemosiderosis in the placental lesion of fetal artery thrombosis: a marker for disturbance of matemofetal transfer? Placenta. 1995;16:171-178.
8. Brenner W, Edelman D, Hendricks C. A standard of fetal growth for the United States of America. Am J Obstet Gynecol. 1976;126:555-564.
9. Benirschke K, Kaufmann P. Normative values and tables. In: Pathology of the Human Placenta. 4th ed. New York, NY: Springer-Verlag; 2000:921-922.
10. Fox G, Van Wesep R, Resau J, et al. The effect of immersion formaldehyde fixation on human placental weight. Arch Pathol Lab Med. 1991;115:726-728.
11. Sander C. Hemorrhagic endovasculitis and hemorrhagic villitis of the placenta. Arch Pathol Lab Med. 1980;104:371-373.
12. Redline R, Ariel I, Baergen R, et al. Fetal vascular obstructive lesions: nosology and reproducibility of placental reaction patterns. Pediatr Dev Pathol. 2004;7:443-452.
13. Altshuler G. Chorangiosis: an important placental sign of neonatal morbidity and mortality. Arch Pathol Lab Med. 1984;108:71-74.
14. Arizawa M, Nakayama M. Suspected involvement of the X chromosome in placental mesenchymal dysplasia. Congenit Anom (Kyoto). 2002;42:309-317.
15. Chen C, Chern S, Wang T, et al. Pregnancy with concomitant chorangioma and placental vascular malformation with mesenchymal hyperplasia. Hum Reprod. 1997;12:2553-2556.
16. Cohen M, Roper E, Sebire N, et al. Placental mesenchymal dysplasia associated with fetal aneuploidy. Prenat Oiagn. 2005;25:187-192.
17. Furuhashi M, Oda H, Nakashima T. Hydrops of placental stem villi complicated with fetal congenital adrenal hyperplasia. Arch Gynecol Obstet. 2000;264:101-104.
18. Gibson BR, Muir-Padilla J, Champeaux A, et al. Mesenchymal dysplasia of the placenta. Placenta. 2004;25:671-672.
19. Hojberg K, Aagaard J, Henriques U, et al. Placental vascular malformation with mesenchymal hyperplasia and a localized chorioangioma: a rarity simulating partial mole. Pathol Res Pract. 1994;190:808-813.
20. Kaiser-Rogers KA, McFadden DE, Livasy CA, et al. Androgenetic/biparental mosaicism causes placental mesenchymal dysplasia. J Med Genet. 2006;43:187-192.
21. Lage J. Placentomegaly with massive hydrops of placental stem villi, diploid DNA content, and fetal omphaloceles: possible association with Beckwith-Wiedemann syndrome. Hum Pathol. 1991;22:591-597.
22. Lee G, Chi J, Cha K. An unusual venous anomaly of the placenta. Am J Clin Pathol. 1991;95:48-51.
23. Matsui H, Iitsuka Y, Yamazawa K, et al. Placental mesenchymal dysplasia initially diagnosed as partial mole. Pathol. Int. 2003;53:810-813.
24. Ohyama M, Kojyo T, Gotoda H, et al. Mesenchymal dysplasia of the placenta. Pathol Int. 2000;50:759-764.
25. Paradinas F, Sebire N, Fisher R, et al. Pseudo-partial moles: placental stem vessel hydrops and the association with Beckwith-Wiedemann syndrome and complete moles. Histopathology. 2001;39:447-454.
26. Pridmore B, Khong TY, Wells WA. Ultrasound placental cysts associated with massive placental stem villous hydrops, diploid DNA content, and exomphalos. Am J Perinatol. 1994;11:14-18.
27. Reinhart R, Wells W, Harris R. Focal aneurysmal dilatation of subchorionic vessels simulating chorioangioma. Ultrasound Obstet Gynecol. 1999;13:147-149.
28. Sander C. Angiomatous malformation of placental chorionic stem vessels and pseudo-partial molar placentas: report of five cases. Pediatr Pathol. 1993;13:621-633.
29. Hillstrom M, Brown D, Wilkins-Haug L, et al. Sonographic appearance of placental villous hydrops associated with Beckwith-Wiedemann syndrome. J Ultrasound Med. 1995;14:61-64.
30. McCowan L, Becroft D. Beckwith-Wiedemann syndrome, placental abnormalities, and gestational proteinuric hypertension. Obstet Gynecol. 1994;83:813-817.
31. Magee J. Investigation of stillbirth. Pediatr Dev Pathol. 2001;4:1-22.
32. Illanes S, Soothill P. Management of fetal growth restriction. Semin Fetal Neonatal Med. 2004;9:395-401.
33. Monk D, Moore G. Intrauterine growth restriction: genetic causes and consequences. Semin Fetal Neonatal Med. 2004;9:371-378.
34. Brodsky D, Christou H. Current concepts in intrauterine growth restriction. J Intensive Care Med. 2004;19:307-319.
35. Benirschke K, Kaufmann P. Benign tumors: chorangiosis. In: Pathology of the Human Placenta. 4th ed. New York, NY: Springer-Verlag; 2000:778-789.
36. Benirschke K. Recent trends in chorangiomas, especially those of multiple and recurrent chorangiomas. Pediatr Dev Pathol. 1999;2:264-269.
37. Redline R. Severe fetal placental vascular lesions in term infants with neurologic impairment. Am J Obstet Gynecol. 2005;192:452-457.
38. Kraus F, Acheen V. Fetal thrombotic vasculopathy in the placenta: cerebral thrombi and infarcts, coagulopathies, and cerebral palsy. Hum Pathol. 1999;30:759-769.
39. Redline R. Clinical and pathological umbilical cord abnormalities in fetal thrombotic vasculopathy. Hum Pathol. 2004;35:1494-1498.
40. Ohama K, Ueda K, Okamoto E, et al. Cytogenetic and clinicopathologic studies of partial moles. Obstet Gynecol. 1986;68:259-262.
41. Jauniaux E, Kadri R, Hustin J. Partial mole and triploidy: screening patients with first-trimester spontaneous abortion. Obstet Gynecol. 1996;88:616-619.
42. Ping A, Reeve A, Law D, et al. Genetic linkage of Beckwith-Wiedemann syndrome to 11p15. Am J Hum Genet. 1989;44:720-723.
43. Weksberg R, Shen D, Fei Y, et al. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome. Nat Genet. 1993;5:143-150.
44. Yamada Y, Nezu J, Shimane M, et al. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D. Genomics. 1997;42:483-488.